Femara shows promise in early stage disease

For women with endocrine-responsive early breast cancer, letrozole (Femara) as the initial adjuvant endocrine therapy may modestly improve overall survival compared with tamoxifen.

Click to read more ...

Sounds like Tamoxifen is doing the trick

Since I’m on Tamoxifen and had very dense breast tissue, this synopsis from the San Antonio Breast Cancer Conference was very gratifying to read:

SAN ANTONIO, Dec. 15 — Tamoxifen’s likely efficacy in preventing breast cancer may be predicted by changes in tissue density on annual mammography scans, researchers found.

Click to read more ...